Like other cancers, several pathophysiologic factors are essential in the progression of gastric cancer, such as inflammation, nuclear factor-κB (NF-κB) activation, immune suppression, etc. NF-κB is involved in cell proliferation and can be activated by G-protein coupled receptors (GPCR). This evidence concerns the gene LPAR2 and cancer.